Modulation of Arachidonic Acid Metabolism by Olsalazine and Other Aminosalicylates in Leukocytes (Q68330014)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1685260%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

title

Modulation of arachidonic acid metabolism by olsalazine and other aminosalicylates in leukocytes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1685260%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

Modulation of Arachidonic Acid Metabolism by Olsalazine and Other Aminosalicylates in Leukocytes (English)

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

28 October 2022

author name string

H. Horn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1685260

28 October 2022

G. Preclik

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1685260

28 October 2022

E. F. Stange

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1685260

28 October 2022

H. Ditschuneit

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1685260

28 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1685260

28 October 2022

publication date

1 August 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1685260%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

23 September 2019

http://www.tandfonline.com/doi/pdf/10.3109/00365529109037024

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

Scandinavian Journal of Gastroenterology

28 October 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1685260%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1685260%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1685260%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

page(s)

867-879

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1685260%20AND%20SRC:MED&resulttype=core&format=json

Prostaglandins and ulcerative colitis

23 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

28 October 2022

Federation Proceedings

4

44

25

Ford-Hutchinson A W

1985

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

Activation of neutrophil chemotaxis by leukotriene B4 and 5-hydroxyeicosatetraenoic acid in chronic inflammatory bowel disease

28 October 2022

5

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

Use of colonic eicosanoid concentrations as predictors of relapse in ulcerative colitis: double blind placebo controlled study on sulphasalazine maintenance treatment

28 October 2022

6

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

Enhanced formation of sulfidopeptide-leukotrienes in ulcerative colitis and Crohn's disease: inhibition by sulfasalazine and 5-aminosalicylic acid

28 October 2022

8

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

Prostaglandin synthetase activity in acute ulcerative colitis: effects of treatment with sulphasalazine, codeine phosphate and prednisolone

28 October 2022

9

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

Olsalazine in the treatment of ulcerative colitis among patients intolerant of sulphasalazine: a prospective, randomized, placebo-controlled, double-blind, dose-ranging clinical trial

28 October 2022

11

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

Olsalazine in active ulcerative colitis

28 October 2022

12

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

Azodisal sodium in the treatment of ulcerative colitis. A study of tolerance and relapse-prevention properties

28 October 2022

13

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

Controlled trial comparing olsalazine and sulphasalazine for the maintenance treatment of ulcerative colitis

28 October 2022

15

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

Clinical Pharmacokinetics of Sulphasalazine

28 October 2022

16

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

Distribution and metabolism in healthy volunteers of disodium azodisalicylate, a potential therapeutic agent for ulcerative colitis

28 October 2022

18

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

Longterm olsalazine treatment: pharmacokinetics, tolerance and effects on local eicosanoid formation in ulcerative colitis and Crohn's colitis

28 October 2022

19

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

An experiment to determine the active therapeutic moiety of sulphasalazine

28 October 2022

20

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease.

28 October 2022

21

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

Possible mode of action of 5-aminosalicylic acid

28 October 2022

23

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

The effect of sulfasalazine and its active components on human polymorphonuclear leukocyte function in relation to ulcerative colitis

28 October 2022

24

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

Inhibition of neutrophil degranulation and superoxide production by sulfasalazine. Comparison with 5-aminosalicylic acid, sulfapyridine and olsalazine

28 October 2022

25

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

The antiinflammatory moiety of sulfasalazine, 5-aminosalicylic acid, is a radical scavenger

28 October 2022

26

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species

28 October 2022

27

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

Studies of prostaglandins and sulphasalazine in ulcerative colitis

28 October 2022

28

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

Analgesic ingestion and other factors preceding relapse in ulcerative colitis

28 October 2022

30

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

Inhibition of 5-lipoxygenase pathway of arachidonic acid metabolism in human neutrophils by sulfasalazine and 5-aminosalicylic acid.

28 October 2022

31

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

A comparison of effects of sulfasalazine and its metabolites on the metabolism of endogenous vs. exogenous arachidonic acid

28 October 2022

32

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

A rapid method for purification of human granulocytes using percoll. A comparison with dextran sedimentation

28 October 2022

34

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

Protein measurement with the Folin phenol reagent

28 October 2022

35

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

Biosynthesis of lipoxygenase and cyclo-oxygenase products from [14C]-arachidonic acid by human colonic mucosa

28 October 2022

36

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

Effect of antacid treatment on endogenous prostaglandin synthesis in human antral and duodenal mucosa

28 October 2022

37

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

In vitro effects of arachidonic acid on the prostaglandin synthesizing system in gastric mucosa.

28 October 2022

38

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

Prostaglandin synthesis along the gastrointestinal tract of the rabbit: differences in total synthesis and profile

28 October 2022

39

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

Abnormal metabolism of arachidonic acid in chronic inflammatory bowel disease: enhanced release of leucotriene B4 from activated neutrophils

28 October 2022

41

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

Characterization of leukotriene A4 and B4 bioysnthesis

28 October 2022

43

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

Metabolism of arachidonic acid by human neutrophils. Characterization of the enzymatic reactions that lead to the synthesis of leukotriene B4

28 October 2022

44

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

American Journal of Physiology

28 October 2022

45

244

G131

Ahlquist D A

1983

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

Inhibition of soybean lipoxygenase by sulfasalazine and 5-aminosalicylic acid: a possible mode of action in ulcerative colitis

28 October 2022

48

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils

28 October 2022

49

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

Modulation of human colonic arachidonic acid metabolism by sulfasalazine.

28 October 2022

50

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

Metabolism of arachidonic acid in acetic acid colitis in rats. Similarity to human inflammatory bowel disease

28 October 2022

51

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

Sulphasalazine is a potent inhibitor of prostaglandin 15-hydroxydehydrogenase: possible basis for therapeutic action in ulcerative colitis

28 October 2022

52

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

Inhibition of platelet thromboxane synthetase by sulfasalazine

28 October 2022

55

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

British Journal of Pharmacology

28 October 2022

56

80

604

Boughton-Smith N K

1983

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

Influence of sulfasalazine, 5-aminosalicylic acid and sulfapyridine on prostanoid synthesis and metabolism in rabbit colonic mucosa

28 October 2022

58

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

Dual effect of sulphasalazine on colonic prostaglandin synthetase

28 October 2022

59

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

Inhibition of prostaglandin synthetase in human rectal mucosa

28 October 2022

60

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

The effect of anti-inflammatory drugs on eicosanoid formation in a chronic model of inflammatory bowel disease in the rat.

28 October 2022

61

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

Effect of anti-inflammatory drugs on xanthine oxidase and xanthine oxidase induced depolymerization of hyaluronic acid

28 October 2022

62

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

Prostaglandin H synthase and hydroperoxides: peroxidase reaction and inactivation kinetics

28 October 2022

63

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

Scandinavian Journal of Clinical and Laboratory Investigation

28 October 2022

65

97

77

Böyum A

1968

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

On agents favoring prostaglandin f formation during biosynthesis

28 October 2022

66

1 reference

https://api.crossref.org/works/10.3109/00365529109037024

28 October 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1685260%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference